All you need to know about semaglutide - the prescription medication that can help with weight loss

Semaglutide is a prescription GLP‑1 receptor agonist used for type 2 diabetes and (in specific formulations/doses) chronic weight management, and strong clinical evidence shows meaningful weight loss when it’s combined with lifestyle change.

Updated on
All you need to know about semaglutide - the prescription medication that can help with weight loss

Key takeaways

  • Semaglutide is a GLP‑1 receptor agonist that can reduce appetite, support blood sugar control, and produce clinically meaningful weight loss when used consistently with lifestyle changes.
  • In STEP 1, semaglutide 2.4 mg weekly plus lifestyle intervention produced ~14.9% average weight loss at 68 weeks, and most participants achieved at least 5% weight loss.
  • Some evidence updates report ~20.7% weight loss at 72 weeks with higher investigational dosing, but outcomes depend on dose, duration, and adherence.
  • Safe use requires medical screening, gradual dose escalation, and awareness of who should avoid or use caution with semaglutide.

All you need to know about semaglutide - the prescription medication that can help with weight loss

Many people first hear about semaglutide as the active ingredient in Ozempic, a medicine approved for type 2 diabetes. also shows semaglutide can be effective for medical weight management, and a higher-dose semaglutide product (Wegovy) is specifically indicated for chronic weight management Research in eligible adults.

Semaglutide can help people who have struggled with weight for years achieve clinically meaningful results, which may improve long-term health when paired with sustainable nutrition and activity habits. If you’re considering semaglutide and want clarity on what products exist, how they’re taken, and what results to expect, this guide is for you.

Wegovy / Ozempic — What are they?

Wegovy is a once-weekly injection that contains semaglutide and is intended for chronic weight management (with lifestyle intervention). Ozempic is also a once-weekly semaglutide injection, but its primary approved use is improving blood sugar control in adults with type 2 diabetes (and it may lead to weight loss as a secondary effect).

Semaglutide belongs to a drug class called GLP‑1 receptor agonists. These medicines support appetite regulation and can reduce cravings, but maintaining a calorie deficit and following an exercise routine remain essential for best results.

How semaglutide works

Semaglutide mimics the action of a naturally occurring hormone called glucagon-like peptide‑1 (GLP‑1). GLP‑1 is released from the gut in response to eating and helps regulate appetite and blood sugar by acting on the brain, pancreas, and gastrointestinal system.

In practical terms, semaglutide can help people feel full for longer, reduce appetite, and support improved blood sugar regulation—especially when combined with consistent lifestyle changes. It also slows gastric emptying (how quickly food leaves the stomach), which can contribute to steadier post-meal blood sugar levels and increased satiety.

Can semaglutide be used for weight loss?

Clinical evidence supports semaglutide as an effective treatment for chronic weight management in eligible adults, particularly at the 2.4 mg weekly dose studied in major trials. In the STEP 1 trial (semaglutide 2.4 mg weekly for 68 weeks plus lifestyle intervention), average weight loss was about 14.9% versus 2.4% with placebo, and 86.4% of participants achieved at least 5% weight loss.

Additional reporting has described investigational higher-dose semaglutide (7.2 mg) results showing around 20.7% average weight loss at 72 weeks, though this reflects trial/program updates rather than the STEP 1 regimen. With Karespot, Ozempic is delivered as part of a structured programme that includes clinician support, coaching, and tracking tools to help patients stay consistent and safe.

How semaglutide helps lower blood sugar

Semaglutide supports blood sugar control primarily through glucose-dependent effects—meaning it helps the pancreas release insulin when blood sugar rises. This mechanism supports improved long-term glycaemic control for many patients with type 2 diabetes and may reduce the risk of diabetes-related complications when combined with broader risk-factor management.

Semaglutide also slows gastric emptying, which can reduce sharp post-meal glucose spikes by spreading nutrient absorption over a longer period. When blood sugar is more stable (and lifestyle habits support energy balance), less excess energy is pushed toward long-term storage pathways that can contribute to weight gain.

Cardiovascular risk reduction (in type 2 diabetes)

In people with type 2 diabetes at high cardiovascular risk, semaglutide has been shown to reduce major adverse cardiovascular events (a composite that includes cardiovascular death, nonfatal heart attack, or nonfatal stroke) compared with placebo in the SUSTAIN‑6 trial. This is one reason semaglutide is discussed not only for glycaemic control and weight, but also for broader risk reduction in appropriately selected patients.

How long does weight loss take?

Results vary: some people notice changes within the first couple of weeks, while others need several weeks to see measurable progress. Weight loss is often nonlinear, and consistency with medication, nutrition, movement, sleep, and follow-ups typically matters more than short-term fluctuations.

Karespot’s approach emphasizes steady, sustainable weight loss under medical guidance rather than quick fixes that are hard to maintain.

How much weight can you expect to lose?

In STEP 1 (2.4 mg semaglutide weekly), average weight loss was ~14.9% at 68 weeks, and a substantial proportion of participants achieved at least 10% and 15% weight loss. Separate trial updates have reported ~20.7% average weight loss at 72 weeks with a higher investigational dose (7.2 mg).

Individual response varies, and outcomes are generally strongest when medication is combined with professional support for nutrition, physical activity, and behaviour change.

How to use semaglutide for weight loss

In STEP 1, semaglutide was initiated at 0.25 mg once weekly for four weeks and increased every four weeks to reach 2.4 mg by week 16, with adjustments if side effects limited dose escalation. Wegovy is supplied in a pre-filled injection pen designed for subcutaneous injection, typically in the abdomen, thigh, or upper arm, as instructed by a clinician.

Used needles should be disposed of safely in an approved sharps container. Always follow the product instructions and the prescriber’s dosing plan.

The maintenance dose

Dose escalation is typically gradual (often every four weeks), allowing time for the body to adjust and helping reduce common gastrointestinal side effects. Ongoing clinician check-ins help tailor the dose to safety, tolerability, and progress.

Who should not use semaglutide for weight loss?

Semaglutide may not be appropriate (or may require special precautions) for people with certain medical conditions or clinical situations, so prescriber review is essential. Examples include allergy to ingredients, pregnancy/breastfeeding or planning pregnancy, significant gastrointestinal disease, and other medical complexities that require individualized decision-making.

This isn’t a complete list, and a Karespot consultation should include medication reconciliation and clinical history review before starting therapy. Safety and suitability come first.

Other weight-loss medications (brief overview)

Other prescription options may be considered depending on clinical profile and availability, and all require healthcare professional guidance. Examples discussed here include oral semaglutide (Rybelsus) for type 2 diabetes (sometimes used off-label for weight), metformin for type 2 diabetes with modest weight effects in some people, dulaglutide (Trulicity) as another GLP‑1 receptor agonist used for diabetes, liraglutide (Saxenda) for weight management, and orlistat (a fat-absorption blocker with frequent GI side effects).

Things to keep in mind before starting semaglutide

Read the package leaflet carefully for dosing, administration technique, storage, disposal, and side effects. Start treatment only after consultation with a qualified prescriber experienced in medical weight management.

During your consultation, your clinician should assess whether semaglutide is appropriate, then build a plan that includes monitoring, lifestyle support, and follow-ups.

Works Cited

All Information you need about GLP-1

Your ultimate GLP-1 guide

Discover the wide range of Karespot weight-loss offerings tailored to your needs

We don't just prescribe medicines; we combine this breakthrough metabolic medication with expert health coaching to target weight loss at both a biological and behavioural level.
Explore our offering